ENTITY
Sciclone Pharmaceuticals

Sciclone Pharmaceuticals (6600 HK)

104
Analysis
Health CareChina
SciClone Pharmaceuticals (Holdings) Limited operates as a biopharmaceutical company. The Company develops produces and sells oncology drug, infectious diseases drugs and other products. SciClone Pharmaceuticals (Holdings) markets its products throughout China.
more
02 Feb 2021 09:54

SciClone Pharma (赛生药业) Pre-IPO: PHIP Updates and Thoughts on Valuation

In this note, we forecast the company's revenue and net profit. We also value the company with reference to peer pharmaceutical companies listed in...

Logo
495 Views
Share
18 Dec 2020 20:56

China Healthcare: Macro Themes

This Insight summarizes the takeaways from a recent China healthcare industry conference.  There is much talk of pressures on the industry, but...

Share
06 Oct 2020 14:29

SciClone Pharma (赛生药业) Pre-IPO: Rejuvenation of Old Drugs

SciClone Pharma was founded in the US but has a focus on sales of oncology and infectious disease drugs in China. The company plans to raise up to...

Logo
610 Views
Share
x